Nectar Lifesciences Limited
NSE: NECLIFE.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sanjiv Goyal
- Employees
- 1,686
- Headquarters
- Chandigarh, India
- IPO year
- 2005
- Market cap
- ₹3.2B
- Website
- https://www.neclife.com
Loading NECLIFE…
Loading profile data…Frequently asked questions about NECLIFE
What does Nectar Lifesciences Limited (NECLIFE.NS) do?
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, m...
Where does NECLIFE.NS trade?
Nectar Lifesciences Limited (NECLIFE.NS) trades on the National Stock Exchange of India.
What sector is NECLIFE.NS in?
Nectar Lifesciences Limited (NECLIFE.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Nectar Lifesciences Limited?
Sanjiv Goyal is the chief executive officer of Nectar Lifesciences Limited (NECLIFE.NS).
Where is Nectar Lifesciences Limited headquartered?
Nectar Lifesciences Limited is headquartered in India.
Does NECLIFE.NS pay a dividend?
Nectar Lifesciences Limited (NECLIFE.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NECLIFE.NS go public?
Nectar Lifesciences Limited (NECLIFE.NS) completed its initial public offering in 2005.